benztropine

benztropine

 [benz´tro-pēn]

an antidyskinetic used as the mesylate salt in the treatment of parkinsonism and for the control of drug-induced extrapyramidal reactions (except tardive dyskinesia); administered orally, intramuscularly, and intravenously.

benztropine

/benz·tro·pine/ (benz´tro-pēn) an antidyskinetic used as the mesylate salt in the treatment of parkinsonism and for the control of drug-induced extrapyramidal reactions.

benztropine

An anticholinergic used to manage parkinsonism, Parkinson’s disease and dystonia.
 
Adverse effects
In high doses can cause nervousness, impaired memory, numbness, listlessness, depression, confusion, excitement, and hallucinations; GI symptoms include dry mouth, constipation, nausea, vomiting, blurred vision, mydriasis, hyperthermia, anhidrosis, urinary retention, dysuria, weakness, rash and tachycardia.

benztropine

Cogentin^® Neurology An anticholinergic used to manage parkinsonism Adverse effects Usually dose related–nervousness, impaired memory, numbness, listlessness, depression, confusion, excitement, hallucinations with high doses; GI–dry mouth, constipation, N&V, blurred vision, mydriasis, hyperthermia, anidrosis, urinary retention, dysuria, weakness, rash, tachycardia

benztropine

Benzatropine, an anticholinergic drug used to control the symptoms of PARKINSON'S DISEASE. A brand name is Cogentin.